Scientists have utilised AI to predict T cell receptors, advancing personalised medicine, and boosting immunotherapy and vaccine development.
Clinical trials of an mRNA vaccine have begun, and researchers expect broadly positive outcomes in the fight against the widespread illness.
Influenza vaccines are recommended annually, but there’s now an increasing number of different vaccine types. Here’s what to know about this year’s shots.
The TGA has just approved a vaccine against RSV for Australians over 60. Here’s where protection is up to for the youngest children, who are also at risk from the virus.
Despite the often-divisive discussions leading up to this state election, the next state parliament should focus on developing community cohesion in public health.
Unequal access to the COVID-19 vaccine fuelled calls for a patent waiver, but any major change needs to ensure a better outcome for developing economies.
If we get a drug for every disease and we put people on a cocktail of drugs when they're 70 years old so that they can live to 110 instead of 100, is that a good thing or not?
Monash University is No.1 in the world for pharmacy and pharmacology, but what does that mean, and how are the university rankings calculated?
The Reserve Bank head is optimistic about 2022, in part because COVID has loosened the government’s purse strings.
To address climate change, we need to apply the same urgent large-scale response we have to COVID-19, and the key to achieving that is to listen more closely to the fury of youth.
The lack of investment in the development and deployment of decentralised diagnostic devices in Australia, most importantly a COVID-19 nucleic acid test, is a public policy failure.
The Morrison government is ramping up its war and security rhetoric, be it COVID or stoking China fears, in an effort to arrest its flagging popularity ahead of the next federal election.
Community pharmacies and pharmacists are important resources in Australia’s vaccine rollout, and right now they’re being under-utilised.
Scientists are well-advanced in mapping the way forward to develop and repurpose medicines for respiratory virus patients in the post-COVID era.
Dr Harry Al-Wassiti, Research Fellow at the Monash Institute of Pharmaceutical Sciences (MIPS), answers the questions about the jab that's on everyone's mind.
COVID-19 has diverted international attention and resources away from peace-building. This increases the risk of global insecurity and instability.
Unprecedented efforts are driving the global push for a safe and effective COVID-19 vaccine. Here's how it's likely to be rolled out in Australia.
We'll struggle to find a vaccine that works perfectly for people who need it most, despite what the headlines say is coming in 2021.
Early analysis suggests Pfizer's COVID-19 vaccine has an efficacy of more than 90%, but more data is still needed.
When Monash University announced world-first COVID-19 research in July, the crucial behind-the-scenes work of a group of PhD students went largely unnoticed.
Stimulus investment after the pandemic presents a "once in a lifetime" opportunity to pivot economies away from emissions-intensive growth, and towards green growth.
A behind-the-scenes look at the two vaccine candidates being developed by Monash University and the Doherty Institute.
The delivery of a COVID-19 vaccine still needs to overcome some ethical hurdles.
Dr Harry Al-Wassiti is now part of a Monash research team striving to find a COVID-19 vaccine, but his path has been far from easy.
Dummy text
